BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 36499598)

  • 1. EPH/Ephrin-Targeting Treatment in Breast Cancer: A New Chapter in Breast Cancer Therapy.
    Psilopatis I; Souferi-Chronopoulou E; Vrettou K; Troungos C; Theocharis S
    Int J Mol Sci; 2022 Dec; 23(23):. PubMed ID: 36499598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. May EPH/Ephrin Targeting Revolutionize Lung Cancer Treatment?
    Psilopatis I; Karniadakis I; Danos KS; Vrettou K; Michaelidou K; Mavridis K; Agelaki S; Theocharis S
    Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The EPH/Ephrin System in Gynecological Cancers: Focusing on the Roots of Carcinogenesis for Better Patient Management.
    Psilopatis I; Pergaris A; Vrettou K; Tsourouflis G; Theocharis S
    Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Artesunate-induced Cellular Effects Are Mediated by Specific EPH Receptors and Ephrin Ligands in Breast Carcinoma Cells.
    Zadeh T; Lucero M; Kandpal RP
    Cancer Genomics Proteomics; 2022; 19(1):19-26. PubMed ID: 34949656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stem-like Cells from Invasive Breast Carcinoma Cell Line MDA-MB-231 Express a Distinct Set of Eph Receptors and Ephrin Ligands.
    Lucero M; Thind J; Sandoval J; Senaati S; Jimenez B; Kandpal RP
    Cancer Genomics Proteomics; 2020; 17(6):729-738. PubMed ID: 33099474
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Attenuation of eph receptor kinase activation in cancer cells by coexpressed ephrin ligands.
    Falivelli G; Lisabeth EM; Rubio de la Torre E; Perez-Tenorio G; Tosato G; Salvucci O; Pasquale EB
    PLoS One; 2013; 8(11):e81445. PubMed ID: 24348920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aberrant DNA methylation and epigenetic inactivation of Eph receptor tyrosine kinases and ephrin ligands in acute lymphoblastic leukemia.
    Kuang SQ; Bai H; Fang ZH; Lopez G; Yang H; Tong W; Wang ZZ; Garcia-Manero G
    Blood; 2010 Mar; 115(12):2412-9. PubMed ID: 20061560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Functions of EphA1 Receptor Tyrosine Kinase in Several Tumors.
    Wu Y; Du Z; Mou J; Qiu X; Chen J; Cai S; Ren D; Xiao F; Zhou G; Yuan C
    Curr Med Chem; 2023; 30(20):2340-2353. PubMed ID: 35996244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ephrin-Eph signaling usage by a variety of viruses.
    de Boer ECW; van Gils JM; van Gils MJ
    Pharmacol Res; 2020 Sep; 159():105038. PubMed ID: 32565311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Viewing the Eph receptors with a focus on breast cancer heterogeneity.
    Nikas I; Ryu HS; Theocharis S
    Cancer Lett; 2018 Oct; 434():160-171. PubMed ID: 30055288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Eph/Ephrin Signaling in the Tumor Microenvironment.
    Ieguchi K; Maru Y
    Adv Exp Med Biol; 2021; 1270():45-56. PubMed ID: 33123992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disruption of ephrin B/Eph B interaction results in abnormal cochlear innervation patterns.
    Zhou CQ; Lee J; Henkemeyer MJ; Lee KH
    Laryngoscope; 2011 Jul; 121(7):1541-7. PubMed ID: 21647913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lithocholic acid is an Eph-ephrin ligand interfering with Eph-kinase activation.
    Giorgio C; Hassan Mohamed I; Flammini L; Barocelli E; Incerti M; Lodola A; Tognolini M
    PLoS One; 2011 Mar; 6(3):e18128. PubMed ID: 21479221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eph-ephrin A system regulates human choriocarcinoma-derived JEG-3 cell invasion.
    Fujiwara H; Nishioka Y; Matsumoto H; Suginami K; Horie A; Tani H; Matsumura N; Baba T; Sato Y; Araki Y; Konishi I
    Int J Gynecol Cancer; 2013 Mar; 23(3):576-82. PubMed ID: 23429488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ena/VASP proteins mediate repulsion from ephrin ligands.
    Evans IR; Renne T; Gertler FB; Nobes CD
    J Cell Sci; 2007 Jan; 120(Pt 2):289-98. PubMed ID: 17179204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of Eph/ephrin tyrosine kinase in malignant glioma.
    Nakada M; Hayashi Y; Hamada J
    Neuro Oncol; 2011 Nov; 13(11):1163-70. PubMed ID: 21856686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of Eph receptors and their ligands, ephrins, during lipopolysaccharide fever in rats.
    Ivanov AI; Steiner AA; Scheck AC; Romanovsky AA
    Physiol Genomics; 2005 Apr; 21(2):152-60. PubMed ID: 15671251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Roles of Eph receptors and ephrins in segmental patterning.
    Xu Q; Mellitzer G; Wilkinson DG
    Philos Trans R Soc Lond B Biol Sci; 2000 Jul; 355(1399):993-1002. PubMed ID: 11128993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coexpression of ephrin-Bs and their receptors in colon carcinoma.
    Liu W; Ahmad SA; Jung YD; Reinmuth N; Fan F; Bucana CD; Ellis LM
    Cancer; 2002 Feb; 94(4):934-9. PubMed ID: 11920461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Eph receptor and ephrin function in breast, gut, and skin epithelia.
    Perez White BE; Getsios S
    Cell Adh Migr; 2014; 8(4):327-38. PubMed ID: 25482622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.